Product
Pfizer class action lawsuit
Pfizer is a defendant in In re: Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No.11), a proposed class action filed on January 6, 2023 in District Court, S.D. New York.
The case is on docket 1:22-mc-03050.
Case details
- Case
- In re: Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No.11)
- Court
- District Court, S.D. New York
- Docket number
- 1:22-mc-03050
- Case filed
- January 6, 2023
What this case is about
This litigation concerns marketing, sales practices, and product-liability claims involving Chantix (varenicline), a smoking-cessation medication. The provided docket information does not describe the specific allegations.
This summary describes the court filings listed below. It is not legal advice, and it does not establish whether you are a member of any class. That is set by the court-approved class definition.
How to check the official record
The full docket is public. If a settlement is approved, the court-appointed administrator, not Sparrow, publishes the claim form, the eligibility criteria, and the filing deadline.
View the docket on CourtListenerFind settlements you can file today
Sparrow tracks class action settlements that are open for claims and fills out the paperwork for you.
Browse open settlementsSparrow is a class action discovery platform, not a law firm, and is unaffiliated with any parties to this case. Case information is drawn from the public court record via CourtListener and may not reflect the most recent filings.